BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1334006)

  • 1. Pancreastatin increases cytosolic Ca2+ in insulin secreting RINm5F cells.
    Sánchez-Margalet V; Lucas M; Goberna R
    Mol Cell Endocrinol; 1992 Oct; 88(1-3):129-33. PubMed ID: 1334006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreastatin inhibits insulin secretion in RINm5F cells through obstruction of G-protein mediated, calcium-directed exocytosis.
    Hertelendy ZI; Patel DG; Knittel JJ
    Cell Calcium; 1996 Feb; 19(2):125-32. PubMed ID: 8689670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreastatin increases free cytosolic Ca2+ in rat hepatocytes, involving both pertussis-toxin-sensitive and -insensitive mechanisms.
    Sánchez-Margalet V; Lucas M; Goberna R
    Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):439-42. PubMed ID: 8373359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of both alpha 1- and alpha 2-adrenoceptors in an insulin-secreting cell line. Parallel studies of cytosolic free Ca2+ and insulin release.
    Ullrich S; Wollheim CB
    Mol Pharmacol; 1985 Aug; 28(2):100-6. PubMed ID: 2991734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreastatin modulates glucose-stimulated insulin secretion from the perfused rat pancreas.
    Ahrén B; Bertrand G; Roye M; Ribes G
    Acta Physiol Scand; 1996 Sep; 158(1):63-70. PubMed ID: 8876749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreastatin inhibits insulin secretion from isolated rat islets: studies on its mechanism of action.
    Lindskog S; Skoglund G; Ahrén B
    Diabetes Res; 1992 Mar; 19(3):119-23. PubMed ID: 1286546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreastatin, a presumed product of chromogranin-A (secretory protein-I) processing, inhibits secretion from porcine parathyroid cells in culture.
    Fasciotto BH; Gorr SU; DeFranco DJ; Levine MA; Cohn DV
    Endocrinology; 1989 Sep; 125(3):1617-22. PubMed ID: 2759035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivity of human pancreastatin and its localization in pancreas.
    Funakoshi A; Jimi A; Yasunami Y; Tateishi K; Funakoshi S; Tamamura H; Yajima H
    Biochem Biophys Res Commun; 1989 Mar; 159(3):913-8. PubMed ID: 2649103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pancreastatin on insulin and pancreatic polypeptide secretion in the dog.
    Inui A; Okita M; Inoue T; Sakatani N; Oya M; Morioka H; Oimomi M; Tatemoto K; Baba S
    Endocrinol Jpn; 1989 Oct; 36(5):733-8. PubMed ID: 2695319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term inhibitory effects of pancreastatin and diazepam binding inhibitor on pancreatic beta-cell deoxyribonucleic acid replication, polyamine content, and insulin secretion.
    Sjöholm A; Funakoshi A; Efendić S; Ostenson CG; Hellerström C
    Endocrinology; 1991 Jun; 128(6):3277-82. PubMed ID: 2036990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cytosolic calcium and insulin secretion by galanin and ATP receptors: interactions of pertussis-toxin-sensitive and -insensitive signalling pathways.
    Lang J; Boulay F; Parker P; Gierschik P; Wollheim CB
    Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):885-91. PubMed ID: 7526849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of pancreastatin on insulin secretion and the exocrine pancreas in rats].
    von Schönfeld J; Müller MK; Neisius I; Geling M; Rünzi M; Goebell H
    Z Gastroenterol; 1991 Oct; 29(10):523-6. PubMed ID: 1781189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosolic free Ca2+ in insulin secreting cells and its regulation by isolated organelles.
    Prentki M; Wollheim CB
    Experientia; 1984 Oct; 40(10):1052-60. PubMed ID: 6436050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreastatin and its 33-49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo.
    Sánchez-Margalet V; Calvo JR; Lucas M; Goberna R
    Gen Pharmacol; 1992 Jul; 23(4):637-8. PubMed ID: 1397969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites.
    Remaury A; Paris H
    J Pharmacol Exp Ther; 1992 Jan; 260(1):417-26. PubMed ID: 1346166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between muscarinic- and adenosine-receptor signalling in the regulation of cytosolic free Ca2+ and insulin secretion.
    Biden TJ; Browne CL
    Biochem J; 1993 Aug; 293 ( Pt 3)(Pt 3):721-8. PubMed ID: 7688958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreastatin inhibits insulin secretion and exocrine pancreatic secretion in the pig.
    Ahrén B; Pierzynowski SG; Weström B; Karlsson B
    Diabetes Res; 1990 Jun; 14(2):93-6. PubMed ID: 2134219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreastatin and islet hormone release.
    Efendić S; Tatemoto K; Mutt V; Quan C; Chang D; Ostenson CG
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7257-60. PubMed ID: 2890162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of porcine pancreastatin on endocrine function of canine pancreas.
    Ohneda A; Koizumi F; Ohneda M
    Tohoku J Exp Med; 1989 Dec; 159(4):291-8. PubMed ID: 2699104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mastoparan increases the intracellular free calcium concentration in two insulin-secreting cell lines by inhibition of ATP-sensitive potassium channels.
    Eddlestone GT; Komatsu M; Shen L; Sharp GW
    Mol Pharmacol; 1995 Apr; 47(4):787-97. PubMed ID: 7723740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.